Enlivex Updates RAIN Token Holdings to $1.14 Billion, NAV Per Share at $4.67
ENLV is trading near its 52-week low of $0.611 (1.8% below the low).
Summary
Enlivex provided an update on its RAIN token holdings, reporting a value of approximately $1.14 billion as of June 20, 2026, resulting in a Treasury NAV per Share of $4.67.
Key Events · Financing and Capital Events · ENLV
-
RAIN Token Holdings Update
Enlivex reported its RAIN token holdings were valued at approximately $1.14 billion as of June 20, 2026. This is a slight decrease from the $1.16 billion reported on May 28, 2026.
-
Treasury NAV per Share
The company's Treasury NAV per Share is $4.67, based on current RAIN token holdings relative to the total number of ordinary shares outstanding.
-
Significant Discrepancy
The reported NAV per share of $4.67 is significantly higher than the current stock price of $0.5999, indicating a large gap between the company's reported digital asset value and its market valuation.
Analysis · ENLV · Life Sciences
This filing updates the valuation of Enlivex's significant RAIN token treasury, which continues to be many times larger than the company's current market capitalization. The reported Treasury NAV per Share of $4.67 stands in stark contrast to the current stock price of $0.5999, highlighting a substantial discrepancy between the company's reported digital asset value and its market valuation. This ongoing situation is a key factor for investors assessing the company's intrinsic value and future potential, especially as the stock trades near its 52-week low.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 41.9% of the 327 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.46%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ENLV was trading at $0.60 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $149.9M. The 52-week trading range was $0.61 to $2.10. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.